CHILDHOOD NON-HODGKINS-LYMPHOMA IN THE 5 NORDIC COUNTRIES - A 5-YEAR POPULATION-BASED STUDY FROM THE NORDIC SOCIETY OF PEDIATRIC HEMATOLOGYAND ONCOLOGY
I. Marky et al., CHILDHOOD NON-HODGKINS-LYMPHOMA IN THE 5 NORDIC COUNTRIES - A 5-YEAR POPULATION-BASED STUDY FROM THE NORDIC SOCIETY OF PEDIATRIC HEMATOLOGYAND ONCOLOGY, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 163-166
Purpose: The comparable health-care organizations and common Cancer Re
gistry for childhood malignancies in the five Nordic countries offered
an opportunity to conduct an epidemiological study on a reasonable nu
mber of childhood non-Hodgkin's lymphoma (NHL) cases collected in a po
pulation-based manner. Material and Methods: All childhood cases (0-14
.9 years at diagnosis) reported during the 5-year period of 1985-1989
to the Nordic Society of Pediatric Hematology and Oncology (NOPHO) Can
cer Registry for childhood malignancies were reviewed and analyzed acc
ording to age, Murphy's stage, gender, site, and survival. Results: Th
e annual incidence of NHL is 0.7 per 100,000 children in the five Nord
ic countries, constituting 5% of all childhood malignancies. Age distr
ibution was even; the male/female ratio was 3:1. Age and stage were sh
own by Cox regression analysis to be independent prognostic factors. O
lder age and lower stage affected outcome favorably. The stage and sit
e distribution was similar to previous reports. Survival data were in
accordance with those expected with modern treatment protocols. Conclu
sions: The incidence and relative frequency of NHL in childhood in the
five Nordic countries is in agreement with previously reported data,
but the even distribution of cases throughout childhood is a new findi
ng. Older age at onset and stage of disease affect outcome favorably,
whereas male gender contrary to acute lymphoblastic leukemia was not f
ound to affect outcome.